Zoetis Other Non Pharmaceuticals — Revenue decreased by 5.7% to $66.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $66.00M to $66.00M. Over 4 years (FY 2021 to FY 2025), Other Non Pharmaceuticals — Revenue shows an upward trend with a 3.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates successful diversification of the product portfolio and deeper penetration into veterinary clinics, while a decrease may suggest competitive pressure in the diagnostics or equipment market.
This metric represents the total revenue generated from the sale of animal health products that fall outside of traditio...
Peers in the animal health and life sciences sectors often report similar revenue streams under 'Diagnostics' or 'Equipment and Services' segments, which are typically evaluated based on their ability to provide recurring revenue and customer stickiness.
zts_segment_other_non_pharmaceuticals_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $57.00M | $60.00M | $58.00M | $58.00M | $63.00M | $63.00M | $66.00M | $68.00M | $64.00M | $61.00M | $61.00M | $61.00M | $65.00M | $62.00M | $65.00M | $66.00M | $63.00M | $64.00M | $70.00M | $66.00M |
| QoQ Change | — | +5.3% | -3.3% | +0.0% | +8.6% | +0.0% | +4.8% | +3.0% | -5.9% | -4.7% | +0.0% | +0.0% | +6.6% | -4.6% | +4.8% | +1.5% | -4.5% | +1.6% | +9.4% | -5.7% |
| YoY Change | — | — | — | — | +10.5% | +5.0% | +13.8% | +17.2% | +1.6% | -3.2% | -7.6% | -10.3% | +1.6% | +1.6% | +6.6% | +8.2% | -3.1% | +3.2% | +7.7% | +0.0% |